SCHEMBL7064614

SCHEMBL7064614

Cc1ccc(S(=O)(=O)ON(N=Cc2ccccc2Br)C(=N)N)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.44
ALDH1A1 P00352 4/20 0.44
LMNA P02545 4/20 0.43
MAPK1 P28482 2/20 0.43
MEN1 O00255 6/20 0.42
KMT2A Q03164 6/20 0.42
HTT P42858 3/20 0.42
GAA P10253 2/20 0.39
MMP2 P08253 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
VDR P11473 1/20 0.34
PTPN1 P18031 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
CYP2D6 P10635 1/20 0.33
DHODH Q02127 1/20 0.33
F2 P00734 2/20 0.33
PRSS1 P07477 2/20 0.33
PRSS2 P07478 2/20 0.33
PRSS3 P35030 2/20 0.33
CA1 P00915 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7065942 0.87 MAPT (0.44) MAPTALDH1A1LMNAMAPK1MEN1
SCHEMBL7062480 0.87 ALDH1A1 (0.47) MAPTALDH1A1LMNAMAPK1MEN1
SCHEMBL914349 0.83 DHODH (0.41) MAPTALDH1A1LMNAMAPK1MEN1
SCHEMBL7066486 0.83 ALDH1A1 (0.44) MAPTALDH1A1LMNAMAPK1MEN1
SCHEMBL7064644 0.83 MAPT (0.44) MAPTALDH1A1LMNAMAPK1MEN1
SCHEMBL7062930 0.83 ALDH1A1 (0.39) MAPTALDH1A1LMNAMAPK1MEN1
SCHEMBL7065861 0.82 MAPT (0.53) MAPTALDH1A1MAPK1MEN1KMT2A
SCHEMBL7065963 0.81 MAPT (0.38) MAPTALDH1A1LMNAMAPK1MEN1
SCHEMBL7064608 0.81 MAPT (0.44) MAPTALDH1A1LMNAMAPK1MEN1
SCHEMBL7062996 0.79 MAPT (0.38) MAPTALDH1A1LMNAMAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313461-A2 THE USE OF BENZYLIDENEAMINOGUANIDINES AND HYDROXYGUANIDINES AS MELANOCORTIN RECEPTOR LIGANDS Melacure Therapeutics AB (SE) 2003-05-28 EP claimed
WO-2002011715-A2 THE USE OF BENZYLIDENEAMINOGUANIDINES AND HYDROXYGUANIDINES AS MELANOCORTIN RECEPTOR LIGANDS MELACURE THERAPEUTICS AB (SE) 2002-02-14 WO claimed